EIP partners join One Nucleus for BioWednesday webinar

No items found.
​
18 May 2020
Tags
Life
Table of contents
  • Toc Heading
  • Toc Heading

This Wednesday, 20th May, EIP Life partners Andy Sharples and Monika Rai will speak at One Nucleus’ BioWednesday webinar on ‘Enabling Access to Medical Technologies - Compulsory Licensing, TRIPS and FRAND’.

Andy and Monika will be joined by University of Leeds Professor Graham Dutfield to talk about lifting the patent barrier to access medicines, including the principles of FRAND and compulsory licensing/ TRIPS Agreement. The discussion will also reference the current COVID-19 situation as an example of how licensing could work.

Further details of the event can be found here.

Related articles

See all articles

EIP appoints Catherine Howell as Partner, marking the firm’s first home‑grown litigation partner
05 March 2026
EIP is pleased to announce the promotion of Catherine Howell to Partner, marking a significant milestone as she becomes the firm’s first home‑grown litigation partner. Catherine joined EIP as a Trainee Solicitor in 2015 and has progressed through every stage of the firm’s litigation practice, most recently serving as Managing Associate.
​
EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
​
EIP Recognised in The Times Best Law Firms 2026
03 December 2025
EIP is proud to be featured in The Times Best Law Firms 2026, a prestigious list based on peer recommendations across the legal industry. This recognition highlights EIP’s commitment to technical excellence, client-focused service, and innovative IP strategies. From high-value patent litigation to strategic portfolio management, EIP continues to deliver results that matter for clients in technology, life sciences, and engineering. This accolade reinforces our position as a trusted leader in intellectual property law.
​